Antibiotice S.A. (BVB:ATB)
2.055
-0.030 (-1.44%)
At close: Feb 25, 2026
Antibiotice Market Cap
Antibiotice has a market cap or net worth of 1.4 billion as of February 25, 2026. Its market cap has decreased by -11.65% in one year.
Market Cap
1.40B
Enterprise Value
1.64B
Revenue
648.96M
Ranking
n/a
PE Ratio
24.60
Stock Price
2.06
Market Cap Chart
Since December 20, 2004, Antibiotice's market cap has increased from 202.01M to 1.40B, an increase of 592.92%. That is a compound annual growth rate of 9.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 1.40B | -14.90% |
| Dec 30, 2025 | 1.64B | -4.30% |
| Dec 30, 2024 | 1.72B | 83.51% |
| Dec 29, 2023 | 936.52M | 146.47% |
| Dec 30, 2022 | 379.98M | -6.60% |
| Dec 30, 2021 | 406.83M | 24.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cris-Tim Family Holding | 1.93B |
| Rompetrol Rafinare | 1.89B |
| Infinity Capital Investments | 1.71B |
| Teraplast | 1.62B |
| Aerostar | 1.59B |
| Sphera Franchise Group | 1.49B |
| Transilvania Investments Alliance | 1.37B |
| SOCEP | 1.23B |